ZIM2
gene geneOn this page
Also known as ZNF656
Summary
ZIM2 (zinc finger imprinted 2, HGNC:12875) is a protein-coding gene on chromosome 19q13.43, encoding Zinc finger imprinted 2 (Q9NZV7). May be involved in transcriptional regulation.
In human, ZIM2 and PEG3 (GeneID:5178) are two distinct genes that share a set of 5’ exons and have a common promoter, and both genes are paternally expressed. Alternative splicing events connect the shared exons either with the remaining 4 exons unique to ZIM2, or with the remaining 2 exons unique to PEG3. This is in contrast to mouse and cow, where ZIM2 and PEG3 genes do not share exons in common, and the imprinting status of ZIM2 is also not conserved amongst mammals. Additional 5’ alternatively spliced transcripts encoding the same protein have been found for the human ZIM2 gene.
Source: NCBI Gene 23619 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 56 total
- Dosage sensitivity (ClinGen): haploinsufficiency no evidence, triplosensitivity no evidence
- MANE Select transcript:
NM_001387356
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:12875 |
| Approved symbol | ZIM2 |
| Name | zinc finger imprinted 2 |
| Location | 19q13.43 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | ZNF656 |
| Ensembl gene | ENSG00000269699 |
| Ensembl biotype | protein_coding |
| Entrez | 23619 |
Gene structure
Transcript identifiers
Ensembl transcripts: 12 — 7 protein_coding, 4 nonsense_mediated_decay, 1 retained_intron
ENST00000593711, ENST00000593931, ENST00000595671, ENST00000596270, ENST00000597281, ENST00000599935, ENST00000601070, ENST00000629319, ENST00000650111, ENST00000689654, ENST00000693159, ENST00000715564
RefSeq mRNA: 11 — MANE Select: NM_001387356
NM_001146326, NM_001146327, NM_001369770, NM_001369771, NM_001369772, NM_001369773, NM_001369774, NM_001387356, NM_001387357, NM_001387358, NM_015363
CCDS: CCDS33123, CCDS92697
Canonical transcript exons
ENST00000629319 — 13 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001387185 | 56789872 | 56789951 |
| ENSE00003029464 | 56774547 | 56775529 |
| ENSE00003471250 | 56817746 | 56817838 |
| ENSE00003499666 | 56826388 | 56826463 |
| ENSE00003535625 | 56822753 | 56822836 |
| ENSE00003541686 | 56779377 | 56779472 |
| ENSE00003620174 | 56781953 | 56782121 |
| ENSE00003637706 | 56836018 | 56836104 |
| ENSE00003643118 | 56823590 | 56823679 |
| ENSE00003663898 | 56824262 | 56824427 |
| ENSE00003678298 | 56818600 | 56818702 |
| ENSE00003686885 | 56821651 | 56821754 |
| ENSE00003833372 | 56840582 | 56840726 |
Expression profiles
Bgee: expression breadth ubiquitous, 151 present calls, max score 95.94.
FANTOM5 (CAGE): breadth broad, TPM avg 14.2231 / max 735.1020, expressed in 329 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 182904 | 14.2231 | 329 |
| 182905 | 1.3960 | 240 |
| 182902 | 0.0554 | 32 |
| 182901 | 0.0425 | 26 |
Top tissues by expression
264 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| oocyte | CL:0000023 | 95.94 | gold quality |
| secondary oocyte | CL:0000655 | 95.76 | gold quality |
| sperm | CL:0000019 | 92.83 | gold quality |
| male germ cell | CL:0000015 | 91.08 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.91 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 86.18 | gold quality |
| cartilage tissue | UBERON:0002418 | 77.64 | gold quality |
| buccal mucosa cell | CL:0002336 | 75.68 | gold quality |
| adrenal tissue | UBERON:0018303 | 71.52 | gold quality |
| ileal mucosa | UBERON:0000331 | 70.57 | silver quality |
| olfactory bulb | UBERON:0002264 | 70.46 | gold quality |
| type B pancreatic cell | CL:0000169 | 70.33 | gold quality |
| left ovary | UBERON:0002119 | 69.39 | gold quality |
| adult organism | UBERON:0007023 | 69.23 | gold quality |
| cerebellar vermis | UBERON:0004720 | 68.67 | gold quality |
| right ovary | UBERON:0002118 | 68.22 | gold quality |
| testis | UBERON:0000473 | 67.18 | gold quality |
| right testis | UBERON:0004534 | 67.16 | gold quality |
| left testis | UBERON:0004533 | 67.05 | gold quality |
| ovary | UBERON:0000992 | 66.75 | gold quality |
| mucosa of urinary bladder | UBERON:0001259 | 66.32 | gold quality |
| diaphragm | UBERON:0001103 | 66.29 | gold quality |
| endothelial cell | CL:0000115 | 65.38 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 65.14 | gold quality |
| ventricular zone | UBERON:0003053 | 65.12 | gold quality |
| primary visual cortex | UBERON:0002436 | 64.81 | gold quality |
| upper arm skin | UBERON:0004263 | 64.78 | gold quality |
| thymus | UBERON:0002370 | 64.76 | gold quality |
| decidua | UBERON:0002450 | 64.56 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 64.53 | silver quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-35 | yes | 68.38 |
| E-HCAD-25 | yes | 10.68 |
| E-ANND-3 | no | 3.10 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
8 targeting ZIM2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3151-5P | 99.86 | 63.83 | 1069 |
| HSA-MIR-92A-2-5P | 99.75 | 67.01 | 2164 |
| HSA-MIR-671-5P | 99.52 | 67.11 | 1277 |
| HSA-MIR-409-3P | 99.50 | 66.33 | 1192 |
| HSA-MIR-4489 | 99.50 | 65.56 | 785 |
| HSA-MIR-4786-3P | 99.36 | 68.35 | 1390 |
| HSA-MIR-140-3P | 99.04 | 67.69 | 1324 |
| HSA-MIR-342-3P | 96.44 | 67.48 | 1344 |
Functional genomics
ClinGen dosage: haploinsufficiency 0 (no evidence), triplosensitivity 0 (no evidence). ClinGen Gene Dosage Map
Literature-anchored findings (GeneRIF, showing 1)
- ZIM2 gene, like the co-transcribed PEG3 gene, is imprinted in human, with preferential expression from the paternal allele. The imprinting status of ZIM2 is not conserved among mammals. (PMID:15203203)
Cross-species orthologs
0 orthologs
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger imprinted 2 — Q9NZV7 (reviewed: Q9NZV7)
Alternative names: Zinc finger protein 656
All UniProt accessions (7): Q9NZV7, A0A3B3ITH6, A0A8I5KWX0, A0AAQ5BIH9, M0QXH8, M0QXI3, M0R155
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Tissue specificity. Highest levels of expression in adult testis; modest levels in fetal kidney and brain.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (11): NP_001139798, NP_001139799, NP_001356699, NP_001356700, NP_001356701, NP_001356702, NP_001356703, NP_001374285, NP_001374286, NP_001374287, NP_056178 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352, PF13894
UniProt features (18 total): compositionally biased region 6, zinc finger region 5, sequence variant 3, region of interest 2, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NZV7-F1 | 49.72 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 52 (showing top):
ATF_B, E2F_Q4_01, E2F4DP1_01, CREBP1_Q2, YY1_Q6, E2F1DP1_01, E2F_Q3, E2F1DP2_01, YY1_02, CREB_Q2_01, E2F1_Q3, GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS, E2F_Q6_01, ATF_01, CREBP1CJUN_01
GO Biological Process (2): regulation of DNA-templated transcription (GO:0006355), regulation of transcription by RNA polymerase II (GO:0006357)
GO Molecular Function (5): DNA binding (GO:0003677), DNA-binding transcription factor activity (GO:0003700), zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 2 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription by RNA polymerase II | 1 |
| nucleic acid binding | 1 |
| transcription cis-regulatory region binding | 1 |
| transcription regulator activity | 1 |
| transition metal ion binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
480 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZIM2 | MEST | Q5EB52 | 814 |
| ZIM2 | GOT1 | P17174 | 784 |
| ZIM2 | USP29 | Q9HBJ7 | 666 |
| ZIM2 | ZIM3 | Q96PE6 | 575 |
| ZIM2 | GRB10 | Q13322 | 548 |
| ZIM2 | NAP1L5 | Q96NT1 | 524 |
| ZIM2 | SNRPN | P14648 | 507 |
| ZIM2 | PEG10 | Q86TG7 | 506 |
| ZIM2 | NNAT | Q16517 | 473 |
| ZIM2 | GNAS | Q5JWF2 | 452 |
| ZIM2 | SGCE | O43556 | 447 |
| ZIM2 | YY1 | P25490 | 435 |
| ZIM2 | COPG2 | Q9UBF2 | 419 |
| ZIM2 | MAGEA6 | P43360 | 417 |
| ZIM2 | NALCN | Q8IZF0 | 400 |
| ZIM2 | MCTS2 | A0A3B3IRV3 | 400 |
IntAct
109 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| EPM2AIP1 | ZIM2 | psi-mi:“MI:0915”(physical association) | 0.600 |
| ZIM2 | BLZF1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZIM2 | GMCL1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZIM2 | TTC23 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BLZF1 | ZIM2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GMCL1 | ZIM2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TTC23 | ZIM2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MDFI | ZIM2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| AQP1 | ZIM2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| POLR1C | ZIM2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| POU6F2 | ZIM2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP12-2 | ZIM2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-6 | ZIM2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-7 | ZIM2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZIM2 | MID2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TEKT4 | ZIM2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BAG4 | ZIM2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP3-2 | ZIM2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HOXA1 | ZIM2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SCNM1 | ZIM2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TCHP | ZIM2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GLYCTK | ZIM2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PATZ1 | ZIM2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| IL16 | ZIM2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCDC120 | ZIM2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| USP2 | ZIM2 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (57): TRIM39 (Affinity Capture-MS), SAV1 (Affinity Capture-MS), TRIM28 (Affinity Capture-MS), TRIM24 (Affinity Capture-MS), STK3 (Affinity Capture-MS), APPBP2 (Affinity Capture-MS), TRIM33 (Affinity Capture-MS), ZCWPW1 (Affinity Capture-MS), ZIM2 (Affinity Capture-MS), ZIM2 (Two-hybrid), ZIM2 (Two-hybrid), ZIM2 (Two-hybrid), ZIM2 (Two-hybrid), ZIM2 (Two-hybrid), ZIM2 (Two-hybrid)
ESM2 similar proteins: A0JPK3, A1YFX5, A2RQG7, A7KBS4, F4JUI3, G3X9G7, O49498, P03131, P04605, P04614, P05909, P0C1K0, P11332, P12453, P18098, P24109, P35965, P98182, Q09424, Q0VCB0, Q19203, Q2YDJ5, Q3UZB0, Q567C6, Q5BI31, Q5EXX3, Q5M948, Q62396, Q6AXY9, Q6PB60, Q6PI77, Q71HP2, Q74124, Q7JUR5, Q7Z142, Q7Z2Y5, Q80YD3, Q86UQ0, Q8C0P7, Q8C6P8
Diamond homologs: A0A1W2PQL4, A6NK75, A6NN14, A6NNF4, A6NP11, A8MQ14, A8MTY0, A8MUV8, A8MXY4, B4DX44, B4DXR9, E9PYI1, O14628, O43345, O75290, O75346, O75373, O75437, O95780, P0CB33, P0DKX0, P0DPD5, P16373, P17019, P17038, P21506, P35789, P52736, P52738, P52744, Q03923, Q03924, Q03936, Q03938, Q05481, Q14586, Q14593, Q14929, Q15928, Q3KNS6
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 35 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Keratinization | 5 | 13.9× | 2e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
56 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 48 |
| Likely benign | 7 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3029 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:56775525:CTCTC:C | acceptor_gain | 1.0000 |
| 19:56781947:ACTT:A | donor_loss | 1.0000 |
| 19:56781949:TTA:T | donor_loss | 1.0000 |
| 19:56781950:TAC:T | donor_loss | 1.0000 |
| 19:56781951:A:AC | donor_gain | 1.0000 |
| 19:56781951:AC:A | donor_gain | 1.0000 |
| 19:56781951:ACC:A | donor_gain | 1.0000 |
| 19:56781951:ACCC:A | donor_loss | 1.0000 |
| 19:56781952:C:CC | donor_gain | 1.0000 |
| 19:56781952:CC:C | donor_gain | 1.0000 |
| 19:56781952:CCC:C | donor_gain | 1.0000 |
| 19:56781952:CCCA:C | donor_gain | 1.0000 |
| 19:56781952:CCCAG:C | donor_gain | 1.0000 |
| 19:56782122:C:CC | acceptor_gain | 1.0000 |
| 19:56782128:C:CT | acceptor_gain | 1.0000 |
| 19:56782128:C:T | acceptor_gain | 1.0000 |
| 19:56782129:A:T | acceptor_gain | 1.0000 |
| 19:56818594:GCTTA:G | donor_loss | 1.0000 |
| 19:56818595:CTTA:C | donor_loss | 1.0000 |
| 19:56818595:CTTAC:C | donor_loss | 1.0000 |
| 19:56818596:TTACC:T | donor_loss | 1.0000 |
| 19:56818597:TAC:T | donor_loss | 1.0000 |
| 19:56818597:TACCG:T | donor_loss | 1.0000 |
| 19:56818598:A:AC | donor_gain | 1.0000 |
| 19:56818598:A:AG | donor_loss | 1.0000 |
| 19:56818599:C:CC | donor_gain | 1.0000 |
| 19:56818599:C:CG | donor_gain | 1.0000 |
| 19:56818615:T:TA | donor_gain | 1.0000 |
| 19:56818698:GCATC:G | acceptor_gain | 1.0000 |
| 19:56818699:CATC:C | acceptor_gain | 1.0000 |
AlphaMissense
3730 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:56775177:G:C | F365L | 0.998 |
| 19:56775177:G:T | F365L | 0.998 |
| 19:56775179:A:G | F365L | 0.998 |
| 19:56774763:G:C | F503L | 0.996 |
| 19:56774763:G:T | F503L | 0.996 |
| 19:56774765:A:G | F503L | 0.996 |
| 19:56774847:G:C | F475L | 0.996 |
| 19:56774847:G:T | F475L | 0.996 |
| 19:56774849:A:G | F475L | 0.996 |
| 19:56774746:A:G | L509P | 0.995 |
| 19:56775261:A:C | F337L | 0.995 |
| 19:56775261:A:T | F337L | 0.995 |
| 19:56775263:A:G | F337L | 0.995 |
| 19:56818611:A:G | L254P | 0.995 |
| 19:56775009:A:C | F421L | 0.994 |
| 19:56775009:A:T | F421L | 0.994 |
| 19:56775011:A:G | F421L | 0.994 |
| 19:56774736:A:C | H512Q | 0.993 |
| 19:56774736:A:T | H512Q | 0.993 |
| 19:56774786:A:G | C496R | 0.992 |
| 19:56781964:A:G | L212P | 0.992 |
| 19:56774820:A:C | H484Q | 0.991 |
| 19:56774820:A:T | H484Q | 0.991 |
| 19:56775160:A:G | L371P | 0.991 |
| 19:56818602:A:G | L257P | 0.991 |
| 19:56774738:G:C | H512D | 0.989 |
| 19:56774808:G:C | H488Q | 0.988 |
| 19:56774808:G:T | H488Q | 0.988 |
| 19:56774830:A:G | L481P | 0.988 |
| 19:56774848:A:G | F475S | 0.988 |
dbSNP variants (sampled 300 via entrez): RS1000023409 (19:56778090 T>G), RS1000033448 (19:56778340 C>T), RS1000036135 (19:56822269 C>G,T), RS1000158955 (19:56808422 C>A), RS1000211714 (19:56808151 G>A), RS1000327050 (19:56785016 G>A,T), RS1000360340 (19:56795534 C>T), RS1000479952 (19:56840974 GC>G,GCC), RS1000543217 (19:56778540 C>T), RS1000559398 (19:56789262 A>C), RS1000626973 (19:56838400 G>A), RS1000700651 (19:56838577 A>G,T), RS1000702039 (19:56796520 G>A,C), RS1000704160 (19:56789666 A>G), RS1000749753 (19:56809868 A>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010242_102 | HDL cholesterol levels | 1.000000e-08 |
| GCST010244_421 | Triglyceride levels | 9.000000e-10 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004612 | high density lipoprotein cholesterol measurement |
| EFO:0004530 | triglyceride measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases expression, increases methylation | 2 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Diazinon | decreases methylation | 1 |
| Fluorouracil | affects reaction, decreases expression | 1 |
| Lead | affects splicing | 1 |
| Cyclosporine | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.